兴奋剂
药代动力学
药效学
药理学
胰高血糖素样肽1受体
受体
医学
化学
内科学
作者
Jingchao Sun,Yao Xiao,Xing Wei,Wenjuan Jiang,Xuefeng Hu,Wenjuan Jiang,Wenjuan Jiang,Qian Jin,Wenjuan Jiang,Hong-Mei Zhang,Peter E Lobie
标识
DOI:10.1016/j.biopha.2024.116965
摘要
GLP-1 receptor agonists are clinically utilized for type 2 diabetes and obesity. In vitro and in vivo preclinical studies were performed to assess the druggability of a novel small molecule GLP-1 receptor biased agonist SAL0112.
科研通智能强力驱动
Strongly Powered by AbleSci AI